The company was listed on the Shanghai Stock Exchange on June 12, 1997. Xi'an Jinhua Pharmaceutical Factory, a subsidiary of the company, is located at No. 202, Keji 4th Road, Xi'an High-tech Industrial Development Zone. It has more than 10 advanced production lines, including an extraction workshop, a special workshop for solutions, tablets, capsules, granules, and Jintiange capsules, and is an industrial production base for artificial tiger bones. It is mainly engaged in the production and sale of orthopedic proprietary Chinese medicines, immunological drugs, etc. The main products are Jintiange capsules, Jinhua brand transfer factor capsules, transfer factor oral liquid, etc. Corporate honors: In July 2021, Jinhua Co., Ltd. won the “2020 China Top 100 Traditional Chinese Medicine Companies List”; in December 2020, Jintiange capsules were selected in the “2020 Clinical Value Proprietary Chinese Medicine Brand List in the field of bone injury medicine”; in December 2020, Jinhua Co., Ltd. was selected as the “2019 Top 100 Chinese Medicine Brand Companies”; in December 2019, Jintiange capsules won the title of superior pharmaceutical product in Shaanxi Province, etc.
No Data